Mario Musella1, Vincenzo Bruni2, Francesco Greco3, Marco Raffaelli4, Marcello Lucchese5, Antonio Susa6, Maurizio De Luca7, Giuseppe Vuolo8, Emilio Manno9, Antonio Vitiello10, Nunzio Velotti10, Rossella D'Alessio2, Enrico Facchiano5, Andrea Tirone8, Giuseppe Iovino9, Gastone Veroux11, Luigi Piazza11. 1. Advanced Biomedical Sciences Department, Naples "Federico II" University, Naples, Italy. Electronic address: Mario.musella@unina.it. 2. University Campus Bio-Medico of Rome, Rome, Italy. 3. Bariatric Surgery Unit, Fondazione Poliambulanza, Brescia, Italy. 4. Endocrine and Metabolic Surgery, Università Cattolica del Sacro Cuore, Rome, Italy. 5. Bariatric and Metabolic Surgery Unit, Santa Maria Nuova Hospital, Florence, Italy. 6. Bariatric Surgery Unit, Gruppo San Donato, Milan, Italy. 7. Montebelluna Treviso Hospital, Treviso, Italy. 8. Department of Surgical Sciences, Bariatric Surgery Unit, University of Siena, Siena, Italy. 9. General and Endocrine Surgery, AORN "A. Cardarelli", Naples, Italy. 10. Advanced Biomedical Sciences Department, Naples "Federico II" University, Naples, Italy. 11. General and Emergency Surgery, ARNAS "G, Garibaldi", Catania, Italy.
Abstract
BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) is the most commonly performed bariatric procedure, while laparoscopic adjustable gastric banding (LAGB) has been for a decade one of the most popular interventions for weight loss. After LSG and LAGB, some patients may require a second surgery due to weight regain or late complications. One anastomosis gastric bypass (OAGB) is a promising bariatric procedure, which provides effective long-term weight loss and has a favorable effect on type 2 diabetes. OBJECTIVES: To retrospectively analyze data from 10 Italian centers on conversion from LAGB and LSG to OAGB. SETTING: High-volume centers for bariatric surgery. METHODS: Prospectively collected data from 10 high-volume centers were retrospectively reviewed. Body mass index (BMI), percentage of excess BMI loss, reasons for redo, remission from co-morbidities (hypertension, diabetes, gastroesophageal reflux, and dyslipidemia), and major complications were recorded. RESULTS: Three hundred patients were included in the study; 196 patients underwent conversion from LAGB to OAGB and 104 were converted from LSG. BMI was 45.1 ± 7 kg/m2 at the time of first intervention, 41.8 ± 6.3 kg/m2 at redo time, and 30.5 ± 5.5 kg/m2 at last follow-up appointment. Mean percentage of excess BMI loss was 13.2 ± 28.2 at conversion and 73.4 ± 27.5 after OAGB. Remission rates from hypertension, diabetes, gastroesophageal reflux, and dyslipidemia were 40%, 62.5%, 58.7% and 52%, respectively. Mean follow-up was 20.8 (range, 6-156) months and overall complications rate was 8.6%. CONCLUSION: Our data show that OAGB is a safe and effective revisional procedure after failed restrictive bariatric surgery.
BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) is the most commonly performed bariatric procedure, while laparoscopic adjustable gastric banding (LAGB) has been for a decade one of the most popular interventions for weight loss. After LSG and LAGB, some patients may require a second surgery due to weight regain or late complications. One anastomosis gastric bypass (OAGB) is a promising bariatric procedure, which provides effective long-term weight loss and has a favorable effect on type 2 diabetes. OBJECTIVES: To retrospectively analyze data from 10 Italian centers on conversion from LAGB and LSG to OAGB. SETTING: High-volume centers for bariatric surgery. METHODS: Prospectively collected data from 10 high-volume centers were retrospectively reviewed. Body mass index (BMI), percentage of excess BMI loss, reasons for redo, remission from co-morbidities (hypertension, diabetes, gastroesophageal reflux, and dyslipidemia), and major complications were recorded. RESULTS: Three hundred patients were included in the study; 196 patients underwent conversion from LAGB to OAGB and 104 were converted from LSG. BMI was 45.1 ± 7 kg/m2 at the time of first intervention, 41.8 ± 6.3 kg/m2 at redo time, and 30.5 ± 5.5 kg/m2 at last follow-up appointment. Mean percentage of excess BMI loss was 13.2 ± 28.2 at conversion and 73.4 ± 27.5 after OAGB. Remission rates from hypertension, diabetes, gastroesophageal reflux, and dyslipidemia were 40%, 62.5%, 58.7% and 52%, respectively. Mean follow-up was 20.8 (range, 6-156) months and overall complications rate was 8.6%. CONCLUSION: Our data show that OAGB is a safe and effective revisional procedure after failed restrictive bariatric surgery.
Authors: Maurizio De Luca; Giacomo Piatto; Giovanni Merola; Jacques Himpens; Jean-Marc Chevallier; Miguel-A Carbajo; Kamal Mahawar; Alberto Sartori; Nicola Clemente; Miguel Herrera; Kelvin Higa; Wendy A Brown; Scott Shikora Journal: Obes Surg Date: 2021-05-03 Impact factor: 4.129
Authors: Maria Vittoria Bertoni; Michele Marengo; Fabio Garofalo; Francesco Volontè; Davide La Regina; Markus Gass; Francesco Mongelli Journal: Obes Surg Date: 2021-08-19 Impact factor: 3.479
Authors: Mario Musella; Antonio Vitiello; Antonio Susa; Francesco Greco; Maurizio De Luca; Emilio Manno; Stefano Olmi; Marco Raffaelli; Marcello Lucchese; Sergio Carandina; Mirto Foletto; Francesco Pizza; Ugo Bardi; Giuseppe Navarra; Angelo Michele Schettino; Paolo Gentileschi; Giuliano Sarro; Sonja Chiappetta; Andrea Tirone; Giovanna Berardi; Nunzio Velotti; Diego Foschi; Marco Zappa; Luigi Piazza Journal: Obes Surg Date: 2022-01-01 Impact factor: 4.129